Literature DB >> 30012939

Prognostic impact of preoperative lymphocyte-to-monocyte ratio in patients with colorectal cancer with special reference to myeloid-derived suppressor cells.

Tatsuo Shimura1, Masahiko Shibata2, Kenji Gonda3, Suguru Hayase4, Wataru Sakamoto4, Hirokazu Okayama4, Shotaro Fujita4, Motonobu Saito4, Tomoyuki Momma4, Shinji Ohki4, Koji Kono4.   

Abstract

AIMS: We aimed to investigate the relationship of colorectal cancer prognosis and inflammatory parameters, including neutrophil-to-lymphocyte ratio (NLR) and lymphocyte-to-monocyte ratio (LMR), with reference to circulating myeloid-derived suppressor cells (MDSCs) in the current study. PATIENTS AND METHODS: Thirty-five patients who underwent curative-intent surgery were enrolled. A receiver-operating characteristic curve (ROC) was used to assess the usefulness of candidates for prognostic factors. Recurrence-free survival (RFS) was calculated using the Kaplan-Meier method, and the candidates for prognostic factors were assessed by a Cox proportional hazard model.
RESULTS: ROC curve analyses determined cutoff values for NLR and LMR as 2.9 and 2.4, respectively. The percentage of MDSCs in patients with LMR ≤ 2.4 was statistically higher than in those with LMR > 2.4 (p = 0.012). The patients with LMR ≤ 2.4 exhibited a statistically lower RFS than those with LMR > 2.4 (p = 0.008). These results were also observed in patients with stage II + III disease. LMR was an independent prognostic factor of RFS in colorectal cancer patients (hazard ratio: 7.757, 95% confidence interval: 1.462-41.152, p = 0.016).
CONCLUSION: Lower LMR was associated with poor prognosis in colorectal cancer patients; whereas, higher circulating MDSCs were observed in patients with lower LMR.

Entities:  

Keywords:  colorectal cancer; lymphocyte-to-monocyte ratio; myeloid-derived suppressor cells; neutrophil-to-lymphocyte-ratio

Mesh:

Year:  2018        PMID: 30012939      PMCID: PMC6141447          DOI: 10.5387/fms.2018-10

Source DB:  PubMed          Journal:  Fukushima J Med Sci        ISSN: 0016-2590


  28 in total

Review 1.  The origin and function of tumor-associated macrophages.

Authors:  A Mantovani; B Bottazzi; F Colotta; S Sozzani; L Ruco
Journal:  Immunol Today       Date:  1992-07

Review 2.  Immunity, inflammation, and cancer.

Authors:  Sergei I Grivennikov; Florian R Greten; Michael Karin
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

3.  Analysis of local chronic inflammatory cell infiltrate combined with systemic inflammation improves prognostication in stage II colon cancer independent of standard clinicopathologic criteria.

Authors:  Natalie Turner; Hui-Li Wong; Arnoud Templeton; Sagarika Tripathy; Te Whiti Rogers; Matthew Croxford; Ian Jones; Mathuranthakan Sinnathamby; Jayesh Desai; Jeanne Tie; Susie Bae; Michael Christie; Peter Gibbs; Ben Tran
Journal:  Int J Cancer       Date:  2015-09-02       Impact factor: 7.396

4.  Prognostic significance of the preoperative lymphocyte-to-monocyte ratio in patients with colorectal cancer.

Authors:  Masatsune Shibutani; Kiyoshi Maeda; Hisashi Nagahara; Yasuhito Iseki; Tetsuro Ikeya; Kosei Hirakawa
Journal:  Oncol Lett       Date:  2016-12-12       Impact factor: 2.967

Review 5.  The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer.

Authors:  Donald C McMillan
Journal:  Cancer Treat Rev       Date:  2012-09-17       Impact factor: 12.111

Review 6.  Inflammation and cancer.

Authors:  Lisa M Coussens; Zena Werb
Journal:  Nature       Date:  2002 Dec 19-26       Impact factor: 49.962

7.  Circulating and tumor-infiltrating myeloid-derived suppressor cells in patients with colorectal carcinoma.

Authors:  Bin Zhang; Zhijun Wang; Liangliang Wu; Meng Zhang; Wei Li; Jianhua Ding; Jun Zhu; Huafeng Wei; Ke Zhao
Journal:  PLoS One       Date:  2013-02-20       Impact factor: 3.240

Review 8.  Tumour-infiltrating inflammation and prognosis in colorectal cancer: systematic review and meta-analysis.

Authors:  Z Mei; Y Liu; C Liu; A Cui; Z Liang; G Wang; H Peng; L Cui; C Li
Journal:  Br J Cancer       Date:  2014-02-06       Impact factor: 7.640

9.  Increased Levels of Circulating and Tumor-Infiltrating Granulocytic Myeloid Cells in Colorectal Cancer Patients.

Authors:  Salman M Toor; Azharuddin Sajid Syed Khaja; Haytham El Salhat; Omar Bekdache; Jihad Kanbar; Mohammed Jaloudi; Eyad Elkord
Journal:  Front Immunol       Date:  2016-12-08       Impact factor: 7.561

10.  The Lymphocyte-to-Monocyte Ratio is a Superior Predictor of Overall Survival in Comparison to Established Biomarkers of Resectable Colorectal Cancer.

Authors:  Joseph C Y Chan; David L Chan; Connie I Diakos; Alexander Engel; Nick Pavlakis; Anthony Gill; Stephen J Clarke
Journal:  Ann Surg       Date:  2017-03       Impact factor: 12.969

View more
  8 in total

1.  Preoperative lymphocyte-to-monocyte ratio predicts postoperative infectious complications after laparoscopic colorectal cancer surgery.

Authors:  Tunyaporn Kamonvarapitak; Akihisa Matsuda; Satoshi Matsumoto; Supaschin Jamjittrong; Nobuyuki Sakurazawa; Youichi Kawano; Takeshi Yamada; Hideyuki Suzuki; Masao Miyashita; Hiroshi Yoshida
Journal:  Int J Clin Oncol       Date:  2019-11-28       Impact factor: 3.402

Review 2.  The role of myeloid-derived suppressor cells in gastrointestinal cancer.

Authors:  Cheng Cui; Penglin Lan; Li Fu
Journal:  Cancer Commun (Lond)       Date:  2021-03-27

3.  Prognostic Significance of the Lymphocyte-to-Monocyte Ratio in Bladder Cancer Undergoing Radical Cystectomy: A Meta-Analysis of 5638 Individuals.

Authors:  Jian-Ying Ma; Gang Hu; Qin Liu
Journal:  Dis Markers       Date:  2019-04-04       Impact factor: 3.434

4.  Prognostic significance of lymphocyte-to-monocyte ratio and platelet-to-lymphocyte ratio in patients with hepatocellular carcinoma undergoing transcatheter arterial chemoembolization and radiofrequency ablation.

Authors:  Yanjun Shen; Huige Wang; Xiangmei Chen; Wendong Li; Jinglong Chen
Journal:  Onco Targets Ther       Date:  2019-09-02       Impact factor: 4.147

Review 5.  Myeloid-Derived Suppressor Cells: A New and Pivotal Player in Colorectal Cancer Progression.

Authors:  Kai Yin; Xueli Xia; Ke Rui; Tingting Wang; Shengjun Wang
Journal:  Front Oncol       Date:  2020-12-15       Impact factor: 6.244

6.  Prognostic Role of Monocytic Myeloid-Derived Suppressor Cells in Advanced Non-Small-Cell Lung Cancer: Relation to Different Hematologic Indices.

Authors:  Asmaa M Zahran; Helal F Hetta; Zeinab Albadry M Zahran; Alaa Rashad; Amal Rayan; Dalia O Mohamed; Zeinab Ahmed Abd Elhameed; Salah M Khallaf; Gaber El-Saber Batiha; Yasir Waheed; Khalid Muhammad; Hanaa Nafady-Hego
Journal:  J Immunol Res       Date:  2021-10-11       Impact factor: 4.818

Review 7.  Modeling of the immune response in the pathogenesis of solid tumors and its prognostic significance.

Authors:  Łukasz Zadka; Damian J Grybowski; Piotr Dzięgiel
Journal:  Cell Oncol (Dordr)       Date:  2020-06-02       Impact factor: 6.730

8.  The prognostic utility of pre-treatment neutrophil-to-lymphocyte-ratio (NLR) in colorectal cancer: A systematic review and meta-analysis.

Authors:  Mate Naszai; Alina Kurjan; Timothy S Maughan
Journal:  Cancer Med       Date:  2021-07-26       Impact factor: 4.452

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.